HomeAbout

TL;DR CNBC


Novavax updated Covid vaccine wins FDA, CDC backing, paving way to reach Americans within days - TL;DR CNBC

Novavax updated Covid vaccine wins FDA, CDC backing, paving way to reach Americans within days

Publishing timestamp: 2023-10-04 09:43:41


Summary

Novavax's updated Covid vaccine has received authorization from the FDA and CDC, making it a valuable alternative to the mRNA shots from Pfizer and Moderna. The vaccine targets the omicron subvariant XBB.1.5 and is expected to be available within the next few days. The vaccine uses protein-based technology and is seen as a way to combat the spread of Covid-19.


Sentiment: POSITIVE

Tickers: NVAXMRNAPFE

Keywords: coronavirusbreaking newsmoderna incsocial issuesimmunizationspharmaceuticalspfizer inccenters for disease control and preventionbiotech and pharmaceuticalsbiotechnologycovid-19sciencehealth care industrynovavax incfdacovid-19 vaccine rolloutbusinessbusiness newspandemicsunited states

Source: https://www.cnbc.com/2023/10/03/fda-approves-novavax-updated-covid-vaccine.html


Developed by Leo Phan